Tercica Gets $48M, Awaits FDA Approval For Growth Factor Drug Feb. 9, 2005 By Jennifer Boggs No Comments
Tercica Gets $48M, Awaits FDA Approval For Growth Factor Drug Feb. 9, 2005 By Jennifer Boggs No Comments
Vicuron Reports Positive Phase III Results, Plans Third-Quarter NDA Feb. 8, 2005 By Jennifer Boggs No Comments
Vicuron Reports Positive Phase III Results, Plans Third-Quarter NDA Feb. 8, 2005 By Jennifer Boggs No Comments
Kyorin Pays $21M For ActivX To Be U.S.-Based Research Center Feb. 3, 2005 By Jennifer Boggs No Comments
